THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 36,719 | $316,885 | 0.00% |
| CWM, LLC | 22 | $0 | 0.00% |
| Covestor Ltd | 16 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 47,710 | $411,737 | 0.00% |
| Farther Finance Advisors, LLC | 27 | $233 | 0.00% |
| BARCLAYS PLC | 23,269 | $201 | 0.00% |
| ROYAL BANK OF CANADA | 9,567 | $83,000 | 0.00% |
| Allworth Financial LP | 13 | $113 | 0.00% |
| JNBA Financial Advisors | 1 | $9 | 0.00% |
| VOYA INVESTMENT MANAGEMENT LLC | 26,524 | $228,902 | 0.00% |
| UBS Group AG | 53,718 | $463,586 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 184 | $1,588 | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 77,735 | $670,853 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 18,637 | $160,838 | 0.00% |
| PRUDENTIAL FINANCIAL INC | 16,505 | $142,438 | 0.00% |
| WHITTIER TRUST CO | 289 | $2,494 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 13,794 | $119,042 | 0.00% |
| QUADRANT CAPITAL GROUP LLC | 52 | $449 | 0.00% |
| OSAIC HOLDINGS, INC. | 138 | $1,191 | 0.00% |
| FMR LLC | 15,901 | $137,226 | 0.00% |
External links
This page lists THERAVANCE BIOPHARMA INC's shareholders in Q3 2023. To view THERAVANCE BIOPHARMA INC's shareholder history, click here.